July 13th - July 14th, 2018


Renaissance Philadelphia Airport Hotel
500 Stevens Dr
Philadelphia, PA 19113

Course Overview
The goal of the summit is to foster collaboration, share best practices and provide a forum for peer-to-peer interaction among Advanced Practice Providers (APP) in clinical practice who are actively engaged in the care of oncology patients.  This summit will provide APP learners a broad overview of the latest developments and important current concepts in the multidisciplinary treatment of oncology patients.  Additionally, the summit offers an intimate learning environment to facilitate interaction between learners and faculty so that clinicians can discuss practical patient management issues and then apply their learning once they return to practice.

Intended Learners
Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, Oncology Pharmacists, and other healthcare professionals involved in the management of oncology patients.

$75 General Registration
$125 Late Registration (two weeks prior)

$35 Student Registration*

* Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact for further information.

Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration a user is required to give certain information (such as name, email/mailing address and payment information). This information is confidential and will only be used to contact you regarding your registration.

Cancellation Policy: To receive a full refund, you must contact us at least 60 days prior to the Summit. For cancellations made after the 60-day deadline, your registration fee will be refunded less a $25 cancellation fee if contacting us at least 10 days prior to the Summit. No refunds will be issued after the 10-day deadline.


Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

Friday, July 13, 2018

7:30am - 8:25am

Registration & Breakfast

Exhibit Hall

8:25am - 8:30am

Welcome & Introductions

General Session

8:30am - 9:30am

Cancer Survivorship Care: The Implementation of Quality Cancer Care

Linda A. Jacobs, PhD, CRNP

9:30am - 10:30am

Track 1: Updates in the Treatment of Non-Hodgkin Lymphoma

Henry Fung, MD, FACP, FRCPE

Track 2: What’s New in the Treatment of
Colorectal Cancer? |
Recent Data Impacting Treatment Decision-Making

Steven J. Cohen, MD

10:30am  - 10:50am


Exhibit Hall

10:50am - 11:50am

The Role of Genomics Testing in Determining Cancer Therapy

Leigha Senter, MS, LGC

11:50am - 12:50pm

Buffet Lunch & Non-CE Symposium
Sponsored by Incyte

Symposium Room 

Recognizing Resistance to and Intolerance of Hydroxyurea in Polycythemia Vera Patients: A Case-based Approach

12:50pm - 1:15pm

Network Refresher

Exhibit Hall

1:15pm - 2:15pm

Chimeric Antigen Receptor (CAR) T-cell Therapy: A Case-based Review for Advanced Practice Providers

Patricia Mangan, RN, MSN, APRN-BC 

2:15pm - 3:15pm

Challenges and Developments in Opioid-induced Constipation
This session is supported by independent educational
grant from AstraZeneca.

Nicole M. Ross, MSN, AOCNP 

3:15pm - 4:15pm

Radiologic Interpretation of Metastatic Lung Cancer

Beth Eaby-Sandy, MSN, CRNP, OCN

Saturday, July 14, 2018

8:00am - 8:30am

Check-in & Breakfast

Exhibit Hall

8:30am - 9:30am

Strategies for Managing Patients with Non-Small Cell Lung Cancer (NSCLC): A Rapidly Changing Landscape

Kristen Kreamer, CRNP, MSN, AOCNP, BC

9:30am - 10:30am

PARP Inhibitors for HER2-Negative Metastatic Breast Cancer: The Time Has Come

Tyler Redelico, PharmD

10:30am - 10:50am


Exhibit Hall

10:50am - 11:50am

Oral Cancer-Directed Therapy: Strategies for Optimizing Outcomes

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC

11:50am - 12:50pm

Buffet Lunch & Non-CE Symposium
Sponsored by Takeda Oncology

Symposium Room

NINLARO® (ixazomib): An Oral Treatment Option

12:50pm - 1:00pm


Exhibit Hall

1:00pm - 2 :00pm

New and Emerging Immunotherapies: Management of Treatment-related Toxicities

Marianne Davies, DNP, ACNP, AOCNP

2:00pm - 3:00pm

Diagnosis and Management of Hematologic Complications of Cancer Treatments

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC


Closing Comments

General Session

On-Site Information

Parking: $10/day

Activity Learning Objectives

  1. Assess evidence-based recommendations for the treatment of various hematologic and non-hematologic malignancies
  2. Outline the requirements for implementing an institutional survivorship care plan
  3. Review the tenets of genomic testing and how results may impact selection of cancer therapy
  4. Anticipate potential adverse reactions associated with cancer treatment regimens or palliative drug therapies and employ prevention and mitigation strategies to reduce morbidity in cancer patients
  5. Interpret imaging study results and communicate appropriate pre-imaging instructions to prepare patients prior to testing
  6. Outline medication management strategies for individuals receiving oral anticancer agents

CE Information

This activity is approved for 11.0 contact hour(s) of continuing education (which includes 4.25 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18063245. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This program has been reviewed and is approved for a maximum of 11 credits available for any one learner with all sessions being eligible for a total of 12 AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.

The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. 

This conference is approved for up to 11.0 credit hours by the Washington State Pharmacy Association. 

This continuing nursing education activity was approved by Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approval valid through 7/14/2020
OCEAN ID #2018-23

How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
To receive documentation of credit, participants must:

  1. Attend the educational activity
  2. Complete the online evaluation form


Renaissance Philadelphia Airport Hotel
500 Stevens Drive
Philadelphia, PA 19113 

To make hotel reservations at the venue and receive a special discounted rate of $129 per night, call 800-468-3571 or 610-521-5900 and identify yourself as part of the APP Oncology Summit.

Deadline for discounted reservation: 
Thursday, June 21, 2018

Planning Committee

Karon Martyn, MSN, ANP, AOCNP 
Abington Jefferson Health
Philadelphia, PA

Susan Roethke, CRNP, MSN, AOCNP, ANP-BC
Fox Chase Cancer Center Temple Health
Philadelphia, PA

Beth Eaby-Sandy, CRNP 
Hospital of the University of Pennsylvania
Philadelphia, PA

Deborah L. Selm-Orr, RN, MS, DNP, AOCN, CRNP 
Cancer Treatment Centers of America
Philadelphia, PA

Brian Lee, PharmD
Horizon CME
Clackamas, OR

Cara Williams, PharmD
Horizon CME
Clackamas, OR